What is Amanda Schmitt's NPI number?

Amanda Schmitt's National Provider Identifier (NPI) is 1083091821, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Amanda Schmitt's specialty?

Amanda Schmitt is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Amanda Schmitt located?

Amanda Schmitt's practice location on file with NPPES is 6946 Forest Ave Ste 200, Richmond, VA 23230-1701.

What is Amanda Schmitt's phone number?

The practice phone number listed in the NPPES registry for Amanda Schmitt is (804) 549-4040.

Does Amanda Schmitt accept Medicare?

Amanda Schmitt is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Amanda Schmitt's NPI active?

Yes — Amanda Schmitt's NPI (1083091821) is active in the NPPES registry as of the last update on 2020-02-27.

IndividualActiveAccepts Medicare

Amanda Schmitt, M.D.

NPI 1083091821 · Dermatology Physician · Richmond, VA

Amanda Schmitt, M.D. is a Dermatology Physician provider in Richmond, VA (NPI 1083091821).

Provider details

NPI number: 1083091821
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Female
Sole proprietor: No
License: 0101267260 (VA)

Practice location

6946 Forest Ave Ste 200

Richmond, VA 23230-1701

Phone: (804) 549-4040

Fax: (804) 549-4032

Street-level locationGet directions

More VA providers

Mailing address

201 Concourse Blvd Ste 200

Glen Allen, VA 23059-5640

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 0101267260 (VA)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(73/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
11 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
4,353 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,347	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	601	$88
Destruction of Precancer Skin Growth, 1 Growth17000	390	$47
Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305	342	$70
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	306	$124
Destruction of Skin Growth, 1-14 Growths17110

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 21 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	157	95
Triamcinolone Acetonide	128	97
Clobetasol Propionate	103	72
Hydrocortisone	84	72
Mupirocin	56	44
Fluorouracil	52	51
Metronidazole	45	31
Ciclopirox	32	14

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$433 across 21 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2015-04-30
Last updated: 2020-02-27
Certified: 2020-02-27

Frequently asked questions

What is Amanda Schmitt's NPI number?: Amanda Schmitt's National Provider Identifier (NPI) is 1083091821, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Amanda Schmitt's specialty?: Amanda Schmitt is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Amanda Schmitt located?: Amanda Schmitt's practice location on file with NPPES is 6946 Forest Ave Ste 200, Richmond, VA 23230-1701.
What is Amanda Schmitt's phone number?: The practice phone number listed in the NPPES registry for Amanda Schmitt is (804) 549-4040.
Does Amanda Schmitt accept Medicare?: Amanda Schmitt is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Amanda Schmitt's NPI active?: Yes — Amanda Schmitt's NPI (1083091821) is active in the NPPES registry as of the last update on 2020-02-27.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,347	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	601	$88
Destruction of Precancer Skin Growth, 1 Growth17000	390	$47
Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305	342	$70
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	306	$124
Destruction of Skin Growth, 1-14 Growths17110

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

157

Triamcinolone Acetonide

128

Clobetasol Propionate

103

Hydrocortisone

Mupirocin

Fluorouracil

Metronidazole

Ciclopirox

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$433 across 21 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments